Type 2 Diabetes Med Might Not Harm Bones After All
Canagliflozin (Invokana, Invokamet) is in a class of medications called SGLT-2 inhibitors. These drugs cause the kidneys to remove excess sugar from the blood and excrete it through urine, which lowers blood sugar levels. This class of drugs has been linked to a number of complications, including kidney injury and serious genital infections.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Canagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Health | Invokana | Sugar | Urology & Nephrology